Tenax plummets on phase 3 failure of pulmonary hypertension drug
· seekingalpha.com
Tenax Therapeutics plunges 89% after TNX-103 phase 3 failure in PH-HFpEF. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...